|
시장보고서
상품코드
2107444
단백질 바이오마커 시장 : 바이오마커 유형별, 용도별, 최종사용자별, 지역별Protein Biomarkers Market, By Biomarker Type, By Application, By End User, By Geography |
||||||
단백질 바이오마커 시장은 2026년에 99억 2,590만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 176억 8,660만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.6%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 99억 2,590만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.60% | 2033년 시장 규모 예측 : | 176억 8,660만 달러 |
단백질 바이오마커란 체액이나 조직 내에 존재하는 분자를 말하며, 연구자, 과학자 또는 임상의가 조직의 기능 상태를 측정하거나, 질환의 진행을 모니터링하거나, 정상·비정상적인 기능 및 치료에 대한 반응을 판단하는 데 도움이 됩니다. 단백질 바이오마커는 암, 심혈관 질환, 신경계 질환의 검출 및 진단, 환자 분류, 감염증, 그리고 치료에 있으며, 귀중한 전략을 제공합니다.
전 세계 단백질 바이오마커 시장은 단백질체학, 질량분석, 차세대 염기서열 분석과 같은 기술의 최근 동향과 보급, 그리고 AI를 활용한 데이터 분석의 응용 확대에 힘입어 눈에 띄게 성장하고 있습니다. 이 시장은 바이오마커 발견 및 검증 플랫폼, 진단 분석법, 시약, 바이오정보학 솔루션으로 구성되어 있으며, 제약 회사, 생명공학 기업, 임상 검사 기관, 계약 연구 기관(CRO), 학술연구 기관에 서비스를 제공하는 동시에 확대되는 정밀 의학의 활용도 지원하고 있습니다.
시장 역학
전 세계 단백질 바이오마커 시장은 암, 심혈관 질환, 당뇨병, 신경퇴행성 질환의 발생률 증가에 힘입어 성장하고 있으며, 이에 따라 신속하고 조기적인 검출 및 진단에 대한 수요가 높아지고 있습니다. 정밀 의학의 실천이 고도화됨에 따라 다중 면역측정법이나 질량분석법과 같은 신기술의 등장 및 단백질체학 기술의 진보로 인해 단백질 바이오마커 검사의 개발과 도입이 탄력을 받고 있습니다. 바이오마커 발견 연구에 대한 지출 증가는 단백질 바이오마커에 기반한 진단법의 개발과 상용화를 더욱 가속화하고 있습니다.
그러나 시장에는 바이오마커 발견 및 검증에 수반되는 높은 비용, 엄격한 규제 요건, 분석법의 표준화 및 재현성과 관련된 문제 등 많은 제약이 존재합니다. 그럼에도 불구하고 액체생검의 적용 확대, 바이오마커 발견에 대한 AI 및 기계학습의 통합, 그리고 현장 진단(Point-of-Care)의 보급 확대는 단백질 바이오마커 시장에 새로운 성장 기회를 가져다줄 것입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 단백질 바이오마커 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻은 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 글로벌 단백질 바이오마커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 단백질 바이오마커 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 단백질 바이오마커 시장 : 바이오마커 유형별, 2021-2033년
제5장 세계의 단백질 바이오마커 시장 : 용도별, 2021-2033년
제6장 세계의 단백질 바이오마커 시장 : 최종사용자별, 2021-2033년
제7장 세계의 단백질 바이오마커 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSAProtein Biomarkers Market is estimated to be valued at USD 9,925.9 Mn in 2026 and is expected to reach USD 17,686.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9,925.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.60% | 2033 Value Projection: | USD 17,686.6 Mn |
Protein biomarkers are molecules in bodily fluid or tissue that help researchers, scientists, or clinicians measure the functional state of a tissue, monitor disease progression, or indicate normal/abnormal function or response to treatment. Protein biomarkers offer a valuable strategy for cancer, cardiovascular and neurological disorder detection and diagnoses, patient stratification, infectious disease, and therapy.
The global protein biomarkers market is growing significantly as a result of recent developments and adoption of technologies such as proteomics, mass spectrometry, and next generation sequencing and the increase in the application of AI driven data analytics. The market consists of biomarker discovery and validation platforms, diagnostic assays, reagents and bioinformatics solutions, and it serves pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations, and academic research institutions, while also supporting the growing use of precision medicine.
Market Dynamics
The global protein biomarkers market is driven by increasing occurrence of cancer, cardiovascular disorders, diabetes and neurodegenerative conditions leading to a demand for quick and early detection and diagnosis. The development and launch of protein biomarker tests is gaining traction with enhanced precision medicine practices and the emergence of novel technologies including multiplex immunoassays, mass spectrometry, and the progress of proteomic technologies. Growing expenditure in biomarker discovery research are further accelerating the development and commercialization of protein biomarker-based diagnostics.
However, a number of constraints are present in the market, such as high costs associated with biomarker discovery and validation, stringent regulatory requirements, and issues related to assay standardization and reproducibility. Nevertheless, expanding applications of liquid biopsy, integration of AI and machine learning in biomarker discovery, and increasing adoption of point-of-care diagnostics will offer new opportunities for growth in protein biomarkers market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global protein biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies, Inc., Merck KGaA, QIAGEN N.V., Bio-Rad Laboratories, Inc., Revvity, Inc., Bio-Techne Corporation, and Quanterix Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global protein biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein biomarkers market
Market Segmentation
- Biomarker Type Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology Protein Biomarkers
- Cardiac Protein Biomarkers
- Inflammatory and Sepsis Protein Biomarkers
- Neurology Protein Biomarkers
- Autoimmune Protein Biomarkers
- Metabolic Protein Biomarkers
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Biomarker Discovery and Validation
- Drug Discovery and Clinical Trial Support
- Assay Development
- Antibody Development
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- IVD and Diagnostic Assay Manufacturers
- Pharmaceutical and Biotechnology Companies
- CROs and Biomarker Testing Service Providers
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Merck KGaA
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Revvity, Inc.
- Bio-Techne Corporation
- Quanterix Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Protein Biomarkers Market, By Biomarker Type
- Global Protein Biomarkers Market, By Application
- Global Protein Biomarkers Market, By End User
- Global Protein Biomarkers Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Protein Biomarkers Market, By Biomarker Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiac Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Inflammatory and Sepsis Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurology Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Autoimmune Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Metabolic Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Protein Biomarkers Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biomarker Discovery and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Drug Discovery and Clinical Trial Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Assay Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Antibody Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Protein Biomarkers Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- IVD and Diagnostic Assay Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CROs and Biomarker Testing Service Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Protein Biomarkers Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Company Profile
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revvity, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quanterix Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
